| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $0.84 (Beat by $0.1) |
| EPS GAAP Actual | $0.84 (Beat by $0.1) |
| Revenue Actual | $0.924168B |
| Revenue Surprise | Beat by $924.168M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 6.195 | 22.74 | 6.15 | 6.24 | 2 |
| Dec 2026 | 9.43 | 14.94 | 9.31674 | 9.56896 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.9 | 0.9 | 0.924168B | 8.44% | 924.17M |
| FQ3 2025 (Sep 2025) | 1.09 | 1.09 | 0.975631B | 5.76% | 975.63M |
| FQ2 2025 (Jun 2025) | 1 | 1 | 1.04755B | 2.95% | 1047.55M |
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 1.00342B | 6.97% | 1003.42M |
| FQ4 2024 (Dec 2024) | 0.45 | 0.45 | 0.846123B | -2.36% | 846.12M |
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 0.919444B | -0.13% | 919.44M |
| FQ2 2024 (Jun 2024) | 2.2 | 2.2 | 1.01662B | 100% | 1016.62M |
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 0.933492B | 3.58% | 933.49M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.0553 | -- | 1.02627 | 1.08138 | 1 |
| FQ3 2027 (Sep 2027) | 1.6363 | -- | 1.59128 | 1.67673 | 1 |
| FQ2 2027 (Jun 2027) | 2.0113 | -- | 1.95597 | 2.061 | 1 |
| FQ1 2027 (Mar 2027) | 1.4474 | -- | 1.40758 | 1.48317 | 1 |
| FQ4 2026 (Dec 2026) | 1.03 | 12.62 | 1.00166 | 1.05545 | 1 |
| FQ3 2026 (Sep 2026) | 1.325 | 17.74 | 1.28855 | 1.35774 | 1 |
| FQ2 2026 (Jun 2026) | 2.02333 | 50.58 | 1.96174 | 2.09471 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.95B | -- | 0.93B | 0.97B | 2 |
| FQ3 2027 (Sep 2027) | 1.08B | -- | 1.06B | 1.1B | 2 |
| FQ2 2027 (Jun 2027) | 1.16B | -- | 1.14B | 1.18B | 2 |
| FQ1 2027 (Mar 2027) | 1.09B | -- | 1.07B | 1.11B | 2 |
| FQ4 2026 (Dec 2026) | 0.92B | -0.87 | 0.9B | 0.93B | 2 |
| FQ3 2026 (Sep 2026) | 1.04B | 5.8 | 1.01B | 1.06B | 2 |
| FQ2 2026 (Jun 2026) | 1.16B | 9.96 | 1.14B | 1.2B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.9 | 0.9 | 100% | |
| FQ3 2025 (Sep 2025) | 1.09 | 1.09 | 100% | |
| FQ2 2025 (Jun 2025) | 1 | 1 | 100% | |
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 100% | |
| FQ4 2024 (Dec 2024) | 0.45 | 0.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 100% | |
| FQ2 2024 (Jun 2024) | 2.2 | 2.2 | 100% | |
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $0.92B | $924.17M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $0.98B | $975.63M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.05B | $1047.55M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1B | $1003.42M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.85B | $846.12M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.92B | $919.44M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.02B | $1016.62M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.93B | $933.49M | 100% |